The Board of Directors of Gujarat Themis Biosyn Ltd. at it’s meeting held on 6th February, 2015 approved the following.
1. Unaudited Financial Results for the quarter ended 31st December, 2014.
i. The income from operations of Gujarat Themis Biosyn Limited (A BIFR referred Company) is as per the plans envisaged by the Management utilizing capacity to the fullest extent.
ii. Income from operations recorded Rs. 2339.13 Lacs during the current nine months ended December, 2014 as against Rs. 2294.10 lacs during the corresponding period last year.
iii. Net profit improved to Rs. 374.75 lacs during the current nine months as against Rs. 317.64 lacs during the corresponding period of the previous year.
iv. EPS (Basic) at Rs.2.58 for the current nine months ended December,2014 as compared to Rs.2.19 during the corresponding period of the last year.
v. Barring unforeseen circumstances, the Company expects to wipe off the negative net worth in 2015-16.
2. The Company has entered into an agreement for manufacturing and supply of finished product to M/s. Lupin Limited on revised terms during the period from 1st April, 2015 to 31st March, 2018.